Clinical trial NCT06673238 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-04-01 → 2026-06-01 3. primary completion date: 2026-04-01 → 2026-06-01 4. enrollment: 96 → 95 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07155668 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-11-01 → 2026-05-28 3. primary completion date: 2026-07-01 → 2026-05-28
Clinical trial NCT07504601: start date: 2026-06-29 → 2026-06-30.
Clinical trial NCT06215716 updates: 1. completion date: 2032-11-01 → 2033-02-01 2. primary completion date: 2032-11-01 → 2033-02-01
Clinical trial NCT07216482: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT05742802 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-28 → 2026-05-27
Clinical trial NCT03667196 updates: 1. completion date: 2027-12-31 → 2032-12-31 2. primary completion date: 2027-12-31 → 2032-12-31 3. collaborators added: Teleflex, Dio 4. collaborators removed: Dio Medical, Biotronik SE & Co. KG
Clinical trial NCT06052631: start date: 2026-06-29 → 2026-06-30.
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
Dividend Declaration